Iktos

Iktos is a leading ‘AI for de novo drug design’ company with offices in France, UK and the US
Iktos technology is built upon the latest developments in deep learning algorithms, for de novo design and AI-driven synthesis planning. Founded in 2016, Iktos has a portfolio of 60 plus real world projects either completed or ongoing. Iktos’s customizable technology offers multiple proprietary algorithms to clients, including large/medium pharma, biotech companies and research institutes globally.